Enthorin Therapeutics is a clinical stage pharmaceutical company founded with the goal of developing innovative therapeutics that target brain circuit dysfunction to improve quality of life for patients, families, and communities.
Company Details
- Employees
- 2
- Address
- The Underlying Biology Of Fragile X Syndrome—a Condition Still Lacking Approved Treatments.
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://enthorin.com
Enthorin Therapeutics Questions
Enthorin Therapeutics's website is https://enthorin.com
Enthorin Therapeutics's LinkedIn profile is https://www.linkedin.com/company/enthorin-therapeutics
Enthorin Therapeutics has
2 employees.
View email and phone details for 2
employees at Enthorin Therapeutics.
Enthorin Therapeutics's industry is
Biotechnology Research
Enthorin Therapeutics's top competitors are
Incyte,
Translucence Biosystems,
Augnition Labs,
Augnition Labs,
Clutchkidz Llc,
Longboard Pharmaceuticals,
Mirum Pharmaceuticals, Inc.,
Verona Pharma,
Alder Hey Children's Nhs Foundation Trust.
Enthorin Therapeutics's categories are Biotechnology Research
